LUCAS AVENUE PRACTICE — All Prescriptions & Medications — Page 8
Practice Code: F84642 | LONDON, E13 0QP
Showing results 351-400 of 538
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Ibuprofen | 34 | 2,951 | £66 | -72.1% ▼ |
| Terbutaline sulphate | 33 | 33 | £261 | -39.2% ▼ |
| Theophylline | 33 | 2,408 | £1.2K | -60.5% ▼ |
| Fluorometholone | 33 | 170 | £56 | +129.1% ▲ |
| Alkyl sulphate | 33 | 7,788 | £204 | +257.1% ▲ |
| Valproic acid | 32 | 1,380 | £449 | -63.2% ▼ |
| Insulin degludec | 32 | 160 | £1.5K | -70.9% ▼ |
| Glimepiride | 32 | 2,072 | £59 | -65.3% ▼ |
| Canagliflozin/metformin | 32 | 1,920 | £1.2K | +113.7% ▲ |
| Hydrocortisone | 32 | 2,040 | £1.0K | -62.1% ▼ |
| Piroxicam | 32 | 4,660 | £121 | -44.3% ▼ |
| Ciprofloxain/dexameth | 32 | 205 | £239 | +4.2% ▲ |
| Emulsifying wax | 32 | 28.0K | £4.3K | +162.7% ▲ |
| 32 | 1,121 | £510 | -53.3% ▼ | |
| Hydroxyzine hydrochloride | 31 | 890 | £28 | -41.8% ▼ |
| Betamethasone sodium phosphate | 31 | 305 | £71 | +19.7% ▲ |
| 31 | 4,300 | £613 | -20.4% ▼ | |
| Co-careldopa (Carbidopa/levodopa) | 30 | 4,818 | £364 | -86.7% ▼ |
| Testosterone | 29 | 2,684 | £1.1K | -62.0% ▼ |
| RtS 1.4 - 2 kcal/g dessert style (milk based) (0913011) | 29 | 104.0K | £1.4K | -24.0% ▼ |
| Methyl salicylate | 29 | 1,290 | £64 | +242.9% ▲ |
| Benzalkonium chloride | 29 | 7,250 | £162 | +152.8% ▲ |
| Ursodeoxycholic acid | 28 | 4,220 | £467 | -57.7% ▼ |
| Cinnarizine | 28 | 3,880 | £178 | -40.2% ▼ |
| Oxycodone hydrochloride/naloxone hydrochloride | 28 | 1,568 | £1.2K | +61.5% ▲ |
| Fludroxycortide | 28 | 34 | £697 | +165.5% ▲ |
| 28 | 1,164 | £874 | +104.9% ▲ | |
| 28 | 3,340 | £577 | -72.4% ▼ | |
| Heparinoid | 27 | 3,375 | £185 | +2.9% ▲ |
| 27 | 491 | £271 | -73.6% ▼ | |
| Dicycloverine hydrochloride | 26 | 2,184 | £2.6K | +119.6% ▲ |
| Alfuzosin hydrochloride | 26 | 1,210 | £481 | -63.7% ▼ |
| Powder 1 - 2.2 kcal/ml soup (0913011) | 26 | 728 | £618 | +238.5% ▲ |
| Powder extensively hydrolysed formula (0913101) | 26 | 67.2K | £1.9K | -63.9% ▼ |
| Amorolfine hydrochloride | 26 | 155 | £191 | +12.6% ▲ |
| Lidocaine | 26 | 1,230 | £1.2K | +126.2% ▲ |
| 26 | 4,440 | £248 | +3.4% ▲ | |
| 26 | 8,970 | £225 | -22.1% ▼ | |
| 26 | 1,660 | £6.1K | -42.5% ▼ | |
| Tapentadol | 25 | 1,764 | £2.2K | -39.3% ▼ |
| Fesoterodine fumarate | 25 | 812 | £68 | -36.6% ▼ |
| 25 | 460 | £978 | +59.3% ▲ | |
| 25 | 1,020 | £767 | -24.4% ▼ | |
| Cabergoline | 24 | 368 | £617 | +54.8% ▲ |
| Dapoxetine hydrochloride | 24 | 162 | £765 | +422.7% ▲ |
| Mometasone furoate/olopatadine hydrochloride | 24 | 24 | £304 | +120.9% ▲ |
| Pimecrolimus | 24 | 1,140 | £709 | +41.7% ▲ |
| 24 | 1,624 | £2.9K | -28.9% ▼ | |
| 24 | 610 | £1.4K | +17.1% ▲ | |
| Salmeterol | 23 | 23 | £640 | -4.4% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.